OBJECTIVE: Previously, we found that the ligation of middle meningeal artery (MMA) was effective for the treatment of human migraine. The aim of the present study was designed to investigate whether heating coagulation of middle meningeal artery was able to regulate the plasma CGRP level and c-fos expression within trigeminal nucleus caudalis in migraine rat model triggered by NTG infusion, so as to explore the possible mechanism by which MMA exerts its anti-migraine effect. METHOD: 48 female Wistar rats were used to set up the migraine rat model by administration of nitroglycerin. Plasma CGRP level was detected by radioimmunoassay. C-fos expression within trigeminal nucleus caudalis was examined by means of both RT-PCR and the Western blot. RESULTS: Injection of 10 mg/kg nitroglycerin was able to trigger the animal model of migraine as evidenced by the appearances of a series of symptoms, such as scratching head frequently, climbing cage and ear red. Meanwhile, the intervention could lead to a marked increase in plasma CGRP level and c-fos expression in trigeminal nucleus caudalis compared with the isotonic saline-treated group. In contrast, heat coagulation of middle meningeal artery could attenuate those sufferings of rat induced by nitroglycerin and decrease plasma CGRP level and c-fos expression in trigeminal nucleus caudalis (PϽ0.05). CONCLUSION: The present study implies that the effective treatment of migraine via heat coagulation of middle meningeal artery may be attributable, at least in part, to containing the release of CGRP and the activation of neurons within trigeminal nucleus caudalis.
Chiari I Malformation in Patients with Dizziness
Gregory Artz, MD (presenter) OBJECTIVE: Investigate the association between MRI findings of Type I Chiari malformation and symptoms of dizziness in patients presenting to a neurotology clinic. METHOD: A retrospective chart review was conducted for 16 patients presenting to our neurotology clinic between 2002 and 2009 found to have Chiari Type I on MRI. All patients presented with symptoms of disequilibrium and/or vertigo. Charts were reviewed for demographics, symptoms, surgical procedures, videonystagmography, and degree of malformation based on radiographic measurements. RESULTS: The prevalence of Chiari Type I malformation in patients presenting to the neurotology clinic with dizziness is 16/6427(0.2%). During this time period, 16 patients were found to have radiographically confirmed Chiari Type I malformations. The mean herniation was 6.3mm with a range of 5-13mm. Videonystagmography testing was done on 12/16 patients and 7/12 were abnormal with a mean RVR of 38%. Two of 16 patients (12.5%) underwent posterior fossa decompression. Surgical patients tended to have more severe symptoms. CONCLUSION: A small subset of patients who present to neurotology clinics with vertigo and/or disequilibrium will have radiographic findings of Chiari Type I malformations without the traditional symptoms of headaches and neurologic disturbances. The dilemma for clinicians is to determine if the radiographic findings are contributing to the patients' symptoms or are an incidental finding. Intervention should only be considered if the herniation is greater than 10mm, a cervical syrinx is present, or patients have the classic Chiari-type symptoms.
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